This is consistent with an accumulating number of studies showing associations between higher GDF‐15 activity (expression, circulating levels) and physical and mental capacities [17, 33], functional ability [30], sarcopenia [31] and cachexia [34, 35] at older age, surrogates of the endpoint here investigated. Here, GDF15 is linked to sarcopenia.